2002
DOI: 10.1016/s0378-5173(02)00347-2
|View full text |Cite
|
Sign up to set email alerts
|

Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
46
0
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(52 citation statements)
references
References 17 publications
5
46
0
1
Order By: Relevance
“…Furthermore, most buffers used for in vitro drug delivery studies with tissue culture are very hydrophilic and contain counter ions, which undermines the solubility of poorly watersoluble compounds (Dollo et al, 1999). There is a need from the biopharmaceutical standpoint to increase the aqueous solubility of poorly-soluble non-ionizable drugs in order to circumvent low and highly variable absorption generally seen with such compounds (Takahashi et al, 2002). Solubilizers such as polyethylene glycol 400 (PEG 400), N-Dimethylacetamide (DMA), Cremophor (Yamashita et al, 2000;Ginski et al, 2000;Saha & Kou, 2000;Takahashi et al, 2002;Watanabe et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, most buffers used for in vitro drug delivery studies with tissue culture are very hydrophilic and contain counter ions, which undermines the solubility of poorly watersoluble compounds (Dollo et al, 1999). There is a need from the biopharmaceutical standpoint to increase the aqueous solubility of poorly-soluble non-ionizable drugs in order to circumvent low and highly variable absorption generally seen with such compounds (Takahashi et al, 2002). Solubilizers such as polyethylene glycol 400 (PEG 400), N-Dimethylacetamide (DMA), Cremophor (Yamashita et al, 2000;Ginski et al, 2000;Saha & Kou, 2000;Takahashi et al, 2002;Watanabe et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…There is a need from the biopharmaceutical standpoint to increase the aqueous solubility of poorly-soluble non-ionizable drugs in order to circumvent low and highly variable absorption generally seen with such compounds (Takahashi et al, 2002). Solubilizers such as polyethylene glycol 400 (PEG 400), N-Dimethylacetamide (DMA), Cremophor (Yamashita et al, 2000;Ginski et al, 2000;Saha & Kou, 2000;Takahashi et al, 2002;Watanabe et al, 2005). In order to avoid potential detrimental effects of solubilizers on epithelial cells, most researchers use arbitrarily chosen low concentrations (usually less than 1%) for transport and metabolism studies.…”
Section: Introductionmentioning
confidence: 99%
“…[23][24][25] Solubility study The solubility of FVS in different vehicles was determined by adding 40 mg of FVS into 1 mL of each vehicle in the centrifugal tube, followed by mixing in a shaker incubator at 37°C for 72 hours. The mixture was then centrifuged at 10,000 rpm for 10 minutes to remove the excess FVS.…”
Section: Optimization Of Blank Microemulsion Prescriptionmentioning
confidence: 99%
“…Propranolol was introduced as a marker to determine the transepithelial ability of the established model (Takahashi et al, 2002). Samples were collected from BL side of cell monolayer at 15, 30, 45, 60, 90 and 120 min respectively and analyzed for the propranolol content by high performance liquid chromatography (HPLC) under literature condition (Ma, 2005).…”
Section: The Establishment and Evaluation Of Cell Modelmentioning
confidence: 99%